{"id":277,"date":"2020-06-17T10:54:15","date_gmt":"2020-06-17T10:54:15","guid":{"rendered":"https:\/\/nclinnovations.org\/covid19monitor\/?p=277"},"modified":"2020-06-17T10:54:46","modified_gmt":"2020-06-17T10:54:46","slug":"16-june-2020-tocilizumab-early-administration-of-tocilizumab-below-fio2-%e2%89%a40-5-significantly-more-effective","status":"publish","type":"post","link":"https:\/\/nclinnovations.org\/covid19monitor\/16-june-2020-tocilizumab-early-administration-of-tocilizumab-below-fio2-%e2%89%a40-5-significantly-more-effective\/","title":{"rendered":"(16 June 2020) Tocilizumab- Early administration of tocilizumab below FiO2 \u22640.5% significantly more effective"},"content":{"rendered":"<div class=\"boldgrid-section\">\n<div class=\"container\">\n<div class=\"row\">\n<div class=\"col-md-12 col-xs-12 col-sm-12\">\n<p class=\"\">Compassionate Use of Tocilizumab in Severe SARS-CoV2 Pneumonia. When late administration is too late<\/p>\n<p class=\"\">https:\/\/doi.org\/10.1101\/2020.06.13.20130088<\/p>\n<p class=\"\">In a compassionate-use basis to patients with SSP hospitalized (excluding intensive care and intubated cases) who required oxygen support to have a saturation &gt;93%. Primary endpoint was intubation or death after 24<br \/>\nhours of its administration. A total of 207 patients were studied and 186 analysed. The mean age was 65 years and 68% were male. A co-existing condition was present in 68 % of cases. At baseline, 114 (61%) required oxygen support with FiO2 &gt;0.5 % and 72 (39%) \u22640.5%. Early administration of tocilizumab, when the need of oxygen support was still below FiO2<br \/>\n\u22640.5%, was significantly more effective than given it in advanced stages (FiO2 &gt;0.5 %), achieving lower rates of intubation or death (13% vs 37% repectively, p&lt;0\u00b7001). The benefit of tocilizumab in severe SARS-Cov-2 pneumonia is only expected when it is administrated before the need of high oxygen support.<\/p>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>Compassionate Use of Tocilizumab in Severe SARS-CoV2 Pneumonia. When late administration is too late https:\/\/doi.org\/10.1101\/2020.06.13.20130088 In a compassionate-use basis to patients with SSP hospitalized (excluding intensive care and intubated cases) who required oxygen support to have a saturation &gt;93%. Primary&hellip; <span class=\"read-more-span\"><a href=\"https:\/\/nclinnovations.org\/covid19monitor\/16-june-2020-tocilizumab-early-administration-of-tocilizumab-below-fio2-%e2%89%a40-5-significantly-more-effective\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;(16 June 2020) Tocilizumab- Early administration of tocilizumab below FiO2 \u22640.5% significantly more effective&#8221;<\/span> <span class=\"genericon genericon-next\"><\/span><\/a><\/span><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"bgseo_title":"","bgseo_description":"","bgseo_robots_index":"index","bgseo_robots_follow":"follow"},"categories":[4,18],"tags":[27],"_links":{"self":[{"href":"https:\/\/nclinnovations.org\/covid19monitor\/wp-json\/wp\/v2\/posts\/277"}],"collection":[{"href":"https:\/\/nclinnovations.org\/covid19monitor\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/nclinnovations.org\/covid19monitor\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/nclinnovations.org\/covid19monitor\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/nclinnovations.org\/covid19monitor\/wp-json\/wp\/v2\/comments?post=277"}],"version-history":[{"count":1,"href":"https:\/\/nclinnovations.org\/covid19monitor\/wp-json\/wp\/v2\/posts\/277\/revisions"}],"predecessor-version":[{"id":278,"href":"https:\/\/nclinnovations.org\/covid19monitor\/wp-json\/wp\/v2\/posts\/277\/revisions\/278"}],"wp:attachment":[{"href":"https:\/\/nclinnovations.org\/covid19monitor\/wp-json\/wp\/v2\/media?parent=277"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/nclinnovations.org\/covid19monitor\/wp-json\/wp\/v2\/categories?post=277"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/nclinnovations.org\/covid19monitor\/wp-json\/wp\/v2\/tags?post=277"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}